为了一款药,辉瑞花了12.5亿美金的首付款+最高48亿美元的里程碑付款,甚至后期还会有销售提成……三生制药的这个合计达60亿美元的合作协议,直接刷新了国内创新药的同类交易记录!有没有可能:这不仅仅是国内个别药企的孤立事件,今年可能会迎来国内创新药的“大年”?先解释一个名词——什么是BD?这次三生制药与辉瑞的交易叫BD,意思是独家授予公司自主研发的创新药在全球(不包括中国内地)的开发、生产、商业化的...
Source Link为了一款药,辉瑞花了12.5亿美金的首付款+最高48亿美元的里程碑付款,甚至后期还会有销售提成……三生制药的这个合计达60亿美元的合作协议,直接刷新了国内创新药的同类交易记录!有没有可能:这不仅仅是国内个别药企的孤立事件,今年可能会迎来国内创新药的“大年”?先解释一个名词——什么是BD?这次三生制药与辉瑞的交易叫BD,意思是独家授予公司自主研发的创新药在全球(不包括中国内地)的开发、生产、商业化的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.